Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

RIPK1 inhibitors might help prevent alopecia areata.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

The inhibitor affects androgen metabolism but not ovarian function.

A(1-7) treatment reduces symptoms of lupus in mice.

Jiawei Erzhiwan helps hair growth in androgenetic alopecia by affecting specific cell pathways.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

Topical Ruxolitinib may safely treat severe hair loss.

Topical JAK inhibitors may help treat hair loss.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

JAK inhibitors might help treat Lichen Planopilaris, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.